Bacillus licheniformis B410 Alleviates Inflammation Induced by Lipopolysaccharide and Salmonella by Inhibiting NF-κB and IRF Signaling Pathways in Macrophages
- PMID: 39739164
- DOI: 10.1007/s12602-024-10440-y
Bacillus licheniformis B410 Alleviates Inflammation Induced by Lipopolysaccharide and Salmonella by Inhibiting NF-κB and IRF Signaling Pathways in Macrophages
Abstract
Foodborne bacterial enteritis is a common clinical disease, and its incidence has risen globally. To screen for functional Bacillus strains with anti-inflammatory properties, tolerance to acid and bile salts, and antagonism against Salmonella, 22 strains of Bacillus were employed as candidate strains in this study. An inflammatory cell model was established using J774-Dual NF-κB/IRF reporter macrophages to identify anti-inflammatory Bacillus. The candidate Bacillus strains were assessed through tolerance to acid and bile salts and antibacterial assays, and their inhibitory effects on the inflammatory responses triggered by S. Enteritidis infection were investigated. The findings demonstrated that B. licheniformis B410 was successfully screened, possessing a significant anti-inflammatory effect by suppressing the NF-κB and IRF signaling pathways. B410 exhibited excellent tolerance to acid and bile salts and displayed a favorable antibacterial effect against Salmonella. Co-incubation of B410 with RAW264.7 macrophages did not influence the cell viability. B. licheniformis B410 could significantly inhibit the expression of pro-inflammatory cytokines IL-1β and TNF-α induced by LPS and promote the expression of the anti-inflammatory cytokine IL-10. Additionally, B410 could markedly inhibit the activation of NF-κB and the production of inflammatory cytokines caused by S. Enteritidis infection in macrophages. This study successfully screened a new strain of B. licheniformis B410 that simultaneously had the capabilities of anti-inflammation, acid and bile salt tolerance, and antagonism against Salmonella, providing a new approach for the screening of functional anti-inflammatory probiotics and the development of anti-inflammatory probiotic therapeutic preparations.
Keywords: Bacillus; Salmonella; Acid and bile salt tolerance; Anti-inflammation; IRF signaling pathway; NF-κB signaling pathway.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests.
Similar articles
-
Screening of Lactobacillus plantarum LPH10 and Its Anti-inflammatory Properties: Acid and Bile Salt Tolerance, Bacteriostatic Activity and Regulation of NF-κB/IRF Pathways.Probiotics Antimicrob Proteins. 2025 Aug 20. doi: 10.1007/s12602-025-10725-w. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 40833721
-
Fermentation of Abelmoschus manihot Extract with Halophilic Bacillus licheniformis CP6 Results in Enhanced Anti-Inflammatory Activities.Nutrients. 2023 Jan 7;15(2):309. doi: 10.3390/nu15020309. Nutrients. 2023. PMID: 36678181 Free PMC article.
-
Anti-inflammatory effect of Lactiplantibacillus plantarum T1 cell-free supernatants through suppression of oxidative stress and NF-κB- and MAPK-signaling pathways.Appl Environ Microbiol. 2023 Oct 31;89(10):e0060823. doi: 10.1128/aem.00608-23. Epub 2023 Sep 13. Appl Environ Microbiol. 2023. PMID: 37702501 Free PMC article.
-
Preventive effects of matrine on LPS-induced inflammation in RAW 264.7 cells and intestinal damage in mice through the TLR4/NF-κB/MAPK pathway.Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113432. doi: 10.1016/j.intimp.2024.113432. Epub 2024 Oct 23. Int Immunopharmacol. 2024. PMID: 39447411
-
Proteoglycan from Bacillus sp. BS11 Inhibits the Inflammatory Response by Suppressing the MAPK and NF-κB Pathways in Lipopolysaccharide-Induced RAW264.7 Macrophages.Mar Drugs. 2020 Nov 24;18(12):585. doi: 10.3390/md18120585. Mar Drugs. 2020. PMID: 33255264 Free PMC article.
References
-
- Xia P, Hou T, Jin H, Meng Y, Li J, Zhan F, Geng F, Li B (2023) A critical review on inflammatory bowel diseases risk factors, dietary nutrients regulation and protective pathways based on gut microbiota during recent 5 years. Crit Rev Food Sci Nutr 25:1–17. https://doi.org/10.1080/10408398.2023.2204147 - DOI
-
- Cohen D, Treygerman O, Ken-Dror S, Sagi O, Strauss M, Parizade M, Goren S, Ezernitchi AV, Rokney A, Keinan-Boker L, Bassal R (2024) Twenty-five years of sentinel laboratory-based surveillance of shigellosis in a high-income country endemic for the disease, Israel, 1998 to 2022. Euro Surveill 29(31):2400022. https://doi.org/10.2807/1560-7917.ES.2024.29.31.2400022 - DOI - PubMed - PMC
-
- Henriquez T, Guerra S, Nerini M, Purchase D, Marvasi M (2024) The tomato variety affects the survival of Shigella flexneri 2a in fruit pericarp. Pathogens 13(5):379. https://doi.org/10.3390/pathogens13050379 - DOI - PubMed - PMC
-
- Rezaei Z, Khanzadi S, Salari A (2021) Biofilm formation and antagonistic activity of Lacticaseibacillus rhamnosus (PTCC1712) and Lactiplantibacillus plantarum (PTCC1745). AMB Express 11(1):156. https://doi.org/10.1186/s13568-021-01320-7 - DOI - PubMed - PMC
-
- Kopacz K, Phadtare S (2022) Probiotics for the prevention of antibiotic-associated diarrhea. Healthcare (Basel) 10(8):1450. https://doi.org/10.3390/healthcare10081450 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources